Meinoah's Subsidiary Receives Drug Registration Certificate for Riociguat Tablets
Jan 12, 2026 16:34
CST Updated
16:34
Menovo
R&D, Manufacturing, and Sales of Specialty Active Pharmaceutical Ingredients (APIs) and Formulations
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
Menovo(Maintain Rights)Announcement on January 12,Menovo's Wholly-Owned Subsidiary, Meinovotiankang, Receives Drug Registration Certificate for Riociguat Tablets from NMPA